Jul 15 |
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
Jul 11 |
United Therapeutics cut at Morgan Stanley on risk-reward setup
|
Jul 11 |
Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term
|
Jul 11 |
United Therapeutics (UTHR) Completes Enrolment in IPF Study
|
Jul 11 |
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
|
Jul 11 |
United Therapeutics’ TETON 2 study achieves full enrolment for IPF treatment
|
Jul 10 |
United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
|
Jul 8 |
Unveiling 6 Analyst Insights On United Therapeutics
|
Jul 1 |
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
|
Jun 28 |
Big Money Elevating United Therapeutics
|